Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Biotechnology and Applied Biochemistry|October 1, 1992
Use of helper-free retroviral vector to direct a high expression of porcine growth hormone in mouse fibroblast cellsL H Hwang, B F Chen, P J Lee, et al.Human Gene Therapy|July 1, 1995
Long-term expression of the biologically active growth hormone in genetically modified fibroblasts after implantation into a hypophysectomized ratB F Chen, W C Chang, S T Chen, et al.Journal of Clinical Gastroenterology|December 1, 1996
Serum hepatitis C virus titers in the progression of type C chronic liver disease. With special emphasis on patients with type 1b infectionJ H Kao, M Y Lai, P J Chen, et al.Gastroenterologia Japonica|May 1, 1993
Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applicationsP J Chen, L H Hwang, L Y Chang, et al.The American Journal of Gastroenterology|March 1, 1996
Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitisJ H Kao, M Y Lai, P J Chen, et al.Biochemical and Biophysical Research Communications|January 27, 1999
An ELISA for RNA helicase activity: application as an assay of the NS3 helicase of hepatitis C virusC C Hsu, L H Hwang, Y W Huang, et al.Biochemical and Biophysical Research Communications|September 25, 1995
Improved gene expression by a modified bicistronic retroviral vectorC L Hsieh, B F Chen, C C Wang, et al.Journal of Medical Virology|January 1, 1995
Unbiased usage of T-cell receptor beta variable region genes in peripheral blood cells of hepatitis C patients: no correlation with superantigen effectC C Wang, L H Hwang, P M Yang, et al.Acta Biochimica Polonica|August 29, 2000
ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapyP Borowski, O Mueller, A Niebuhr, et al.Journal of Virology|August 3, 2001
Structure-based mutational analysis of the hepatitis C virus NS3 helicaseC L Tai, W C Pan, S H Liaw, et al.Pageof 5